Fosun Pharma announces 1Q2014 Results 1Q Operating Income Up by 29.24% Year on Year
29 April 2014, Fosun Pharmaceutical (Group) Co., Ltd. ("Fosun Pharma" or the “Company”; stock code: 600196-SH, 02196-HK), a leading healthcare company in the PRC, is pleased to announce its operating results for the first quarter ended 31 March 2014.
In the first quarter of 2014, the Company's operating income grew by 29.24% year on year to RMB2.658 billion and its net profit attributable to Shareholders of the Company increased by 17.59% year on year to RMB414 million.
The management of the Company indicated that Company will continue to adhere to the strategies of organic growth, external expansion and integrated development in 2014. It will center its operations on the core business of pharmaceuticals and healthcare and focus on product innovation and management improvement. Meanwhile, it will also grasp the opportunities in the pharmaceutical market and industry to expand its healthcare services segment.
In the first quarter of 2014, the Company's operating income grew by 29.24% year on year to RMB2.658 billion and its net profit attributable to Shareholders of the Company increased by 17.59% year on year to RMB414 million.
The management of the Company indicated that Company will continue to adhere to the strategies of organic growth, external expansion and integrated development in 2014. It will center its operations on the core business of pharmaceuticals and healthcare and focus on product innovation and management improvement. Meanwhile, it will also grasp the opportunities in the pharmaceutical market and industry to expand its healthcare services segment.